Pharmaceutical stocks are the largest global asset class when considered by Market Cap and remain the biggest constituent part of the US market but BioTech, medical devices and life sciences companies are all commanding an increasingly larger share of the healthcare economy.
Accurately estimating the size of the global healthcare market is an enormous and notoriously difficult exercise, with most calculations lagging months if not years behind the reality. HolonIQ’s analysis of global healthcare stocks provides a real-time picture of one of the world’s largest and most important industries. At a global level pharmaceutical companies continue to dominate lists of healthcare stocks, accounting for the vast majority of the market in the United Kingdom, Denmark, India, Switzerland, France and Japan.
Measured on revenue alone, healthcare stocks accounted for a staggering $5T in 2021
Dwarving the rest of the world are the colossal US health stock market giants, reflecting both the maturity of the US public markets and the rising percentage of GDP the nation spends on its healthcare (close to 20%) at last count. If the US healthcare system was a country it would be the world’s third largest economy.
